Research

Hormonal

Increased levels of specific fatty acid metabolites (3-hydroxylaurate, 3-hydroxyoctanoate, 3-hydroxydecanoate, 3-hydroxymyristate) and decreased levels of 1,5-anhydroglucitol (1,5-AG) and dimethylarginine (ADMA+SDMA) are associated with disease progression from insulin resistance to Type 2 Diabetes.

For individuals with obesity and insulin resistance, monitoring specific fatty acid metabolites and 1,5-AG levels may provide early warning signs of progression to Type 2 Diabetes. Decreasing 1,5-AG and increasing certain hydroxy-fatty acids are associated with this progression, suggesting these could be valuable markers for early intervention.

ModerateSupportsMEDIUM confidence
Figure 2 demonstrates patterns of increased (3-hydroxy-3-hydrocyoctanoate, 3-hydroxylaurate, 3-hydroxydecanoate, 3-hydroxymyristate, and glucose) or decreased (1,5-AG, ADMA + SDMA, homoarginine, ornithine, 2-oxoarginine) metabolites with disease progression.
Haya Al‐Sulaiti et al. · Journal of Translational Medicine · 2019

Why this rating

Based on a pilot observational study with small group sizes and cross-sectional data.

Source

Metabolic signature of obesity-associated insulin resistance and type 2 diabetes

Haya Al‐Sulaiti et al. · Journal of Translational Medicine · 2019

DOI 10.1186/s12967-019-2096-8

cross_sectional · n=107Cited 179×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →